BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2587585)

  • 1. Phylogeny of the plasma regulatory proteins of the complement system.
    Kaidoh T; Gigli I
    Prog Clin Biol Res; 1989; 297():199-209. PubMed ID: 2587585
    [No Abstract]   [Full Text] [Related]  

  • 2. Phylogeny of regulatory proteins of the complement system. Isolation and characterization of a C4b/C3b inhibitor and a cofactor from sand bass plasma.
    Kaidoh T; Gigli I
    J Immunol; 1989 Mar; 142(5):1605-13. PubMed ID: 2918226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogeny of C4b-C3b cleaving activity: similar fragmentation patterns of human C4b and C3b produced by lower animals.
    Kaidoh T; Gigli I
    J Immunol; 1987 Jul; 139(1):194-201. PubMed ID: 3295051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement cofactor protein (SBP1) from the barred sand bass (Paralabrax nebulifer) mediates overlapping regulatory activities of both human C4b binding protein and factor H.
    Kemper C; Zipfel PF; Gigli I
    J Biol Chem; 1998 Jul; 273(31):19398-404. PubMed ID: 9677357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR; Forristal J; Beischel L
    J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of serum complement proteins.
    Colten HR; Goldberger G
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):775-80. PubMed ID: 503698
    [No Abstract]   [Full Text] [Related]  

  • 8. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.
    Fischer E; Ouaissi MA; Velge P; Cornette J; Kazatchkine MD
    Immunology; 1988 Oct; 65(2):299-303. PubMed ID: 2973433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
    Leist-Welsh P; Bjornson AB
    J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
    [No Abstract]   [Full Text] [Related]  

  • 10. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5.
    Ramu P; Tanskanen R; Holmberg M; Lähteenmäki K; Korhonen TK; Meri S
    FEBS Lett; 2007 May; 581(9):1716-20. PubMed ID: 17418141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM; Gleich GJ
    J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I; Sorvillo J; Halbwachs-Mecarelli L
    J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB; Clemenza L; Krych M; Atkinson JP
    J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative pathway of complement is activated during in vitro ventricular assist.
    Chen JC; Huynh TN; Serna DL; Sun CP; Ha H; Steward E; Webster S; Brenner M
    J Investig Med; 1999 Nov; 47(9):502-6. PubMed ID: 10572381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ig N-glycan orientation can influence interactions with the complement system.
    White KD; Cummings RD; Waxman FJ
    J Immunol; 1997 Jan; 158(1):426-35. PubMed ID: 8977219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complement factors in the medical analysis laboratory].
    Laurell AB
    Ric Clin Lab; 1978; 8 Suppl 2():61-74. PubMed ID: 106451
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proteases in complement system (author's transl)].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.